Xenon Pharmaceuticals, Inc. (XENE)
54.16
+0.18
(+0.33%)
USD |
NASDAQ |
May 27, 13:43
Xenon Pharmaceuticals Total Liabilities (Quarterly) : 48.99M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Aurinia Pharmaceuticals, Inc. | 156.37M |
| Alkermes Plc | 2.507B |
| Edesa Biotech, Inc. | 2.188M |
| ProMIS Neurosciences, Inc. | 6.694M |
| Tyra Biosciences, Inc. | 24.46M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.387B |
| Shareholders Equity (Quarterly) | 1.338B |
| Debt to Equity Ratio | 0.0056 |
| Current Ratio | 27.79 |
| Net Debt Paydown Yield | 0.01% |